'DES daughters' with rare cancer continue to face higher death rates

(Reuters Health) - Women who were exposed to the synthetic estrogen diethylstilbestrol (DES) in utero, and who subsequently developed a rare type of vaginal and cervical cancer, continue to face a higher rate of death between the ages of 35 and 65, according to a new study in the New England Journal of Medicine.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news